Atopic dermatitis Trials in Beverly, United States
Conditions / Atopic dermatitis / Beverly, United States
Atopic dermatitis is a medical condition with active clinical research programs worldwide.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04250337 | Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. | COMPLETED | PHASE3 |
| NCT05131477 | Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study | COMPLETED | PHASE2 |
| NCT04178967 | Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT03569293 | Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) | COMPLETED | PHASE3 |
| NCT03443024 | A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis | COMPLETED | PHASE2 |
| NCT05158023 | Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis | COMPLETED | PHASE2 |
| NCT03568331 | Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE) | COMPLETED | PHASE3 |
| NCT04392154 | Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) | COMPLETED | PHASE3 |
| NCT03011892 | A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis | COMPLETED | PHASE2 |
| NCT05469464 | Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) | COMPLETED | PHASE2 |